Polygalacic acid attenuates cognitive impairment by regulating inflammation through PPAR γ/NF-κB signaling pathway
CONCLUSIONS: PA is expected to provide a valuable candidate for new drug development for AD in the future.PMID:38421141 | DOI:10.1111/cns.14581
Source: CNS Neuroscience and Therapeutics - Category: Neuroscience Authors: Tan Zhao Jianping Jia Source Type: research
More News: Alzheimer's | Brain | China Health | Drugs & Pharmacology | Neurology | Neuroscience | Study